Search

Your search keyword '"Ear, Middle metabolism"' showing total 533 results

Search Constraints

Start Over You searched for: Descriptor "Ear, Middle metabolism" Remove constraint Descriptor: "Ear, Middle metabolism"
533 results on '"Ear, Middle metabolism"'

Search Results

51. Discovery of a Biological Mechanism of Active Transport through the Tympanic Membrane to the Middle Ear.

52. SuperSILAC Quantitative Proteome Profiling of Murine Middle Ear Epithelial Cell Remodeling with NTHi.

53. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].

54. Polymorphisms in Toll-like receptors 2 and 4 genes and their expression in chronic suppurative otitis media.

55. Eosinophilic Mucin Otomastoiditis and Otopolyposis: A Progressive Form of Eosinophilic Otitis Media.

56. Expression and Localization of Aquaporin Water Channels in Human Middle Ear Epithelium.

57. Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.

58. [The expression and clinical significance of pepsin and pepsinogen in patients with otitis media with effusion].

59. Divergent expression of α-ENaC in middle ear mucosa in the course of otitis media with effusion induced by barotrauma.

60. Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone.

61. Increased susceptibility to otitis media in a Splunc1-deficient mouse model.

62. Determination of the glycosylation-pattern of the middle ear mucosa in guinea pigs.

63. The transcriptome of a complete episode of acute otitis media.

64. Differential gene expression in the otic capsule and the middle ear--an annotation of bone-related signaling genes.

65. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.

66. A melting method for RNA extraction from the mucosal membrane of the mouse middle ear.

67. Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review.

68. Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection.

69. Bone signaling in middle ear development: a genome-wide differential expression analysis.

70. Mucosal trauma induced apoptosis in guinea pig middle ear: comparision of hemostatic agents.

71. Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.

72. Otitis media in sperm-associated antigen 6 (Spag6)-deficient mice.

73. Pou3f4-mediated regulation of ephrin-b2 controls temporal bone development in the mouse.

74. FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice.

75. A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation.

76. Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.

77. NOD2/RICK-dependent β-defensin 2 regulation is protective for nontypeable Haemophilus influenzae-induced middle ear infection.

78. Magnetic resonance imaging of the middle and inner ear after intratympanic injection of a gadolinium-containing gel.

79. Otitis media impacts hundreds of mouse middle and inner ear genes.

80. Toll-like receptors, cytokines & nitric oxide synthase in patients with otitis media with effusion.

81. Otitis media in the Tgif knockout mouse implicates TGFβ signalling in chronic middle ear inflammatory disease.

82. Cholesteatoma fibroblasts promote epithelial cell proliferation through overexpression of epiregulin.

83. Acquired cholesteatoma: summary of the cascade of molecular events.

86. Expression of toll-like receptors in chronic otitis media and cholesteatoma.

87. Tympanic border cells are Wnt-responsive and can act as progenitors for postnatal mouse cochlear cells.

88. Expression of RANKL and proliferation abilities of cultured human middle ear cholesteatoma epithelial cells.

89. Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal study in rabbits.

90. In situ tissue engineering with synthetic self-assembling peptide nanofiber scaffolds, PuraMatrix, for mucosal regeneration in the rat middle-ear.

91. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.

92. The Haemophilus influenzae Sap transporter mediates bacterium-epithelial cell homeostasis.

93. Otitis media: molecular impact of inflammation in the middle and inner ear--cytokines, steroids, and ion homeostasis.

94. Role of GERD in children with otitis media with effusion.

95. Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II.

96. Ciglitazone inhibits cigarette smoke solution-induced inflammatory responses in human middle ear epithelial cells.

97. Noninvasive in vivo optical detection of biofilm in the human middle ear.

98. Size-dependent passage of liposome nanocarriers with preserved posttransport integrity across the middle-inner ear barriers in rats.

99. Lipoteichoic acid from Staphylococcus aureus induced expression of MMP-9 in human middle ear epithelial cells.

100. Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones.

Catalog

Books, media, physical & digital resources